# persona_off · expbench · iclr2024/19281/1

[All trial-1 traces](../../README.md)

- Trial: **1**; endpoint: **original**; attempt: **1**.
- Native status: **completed**; normalized native score: **22/100**.
- Recorded protocol: `researcher-review-v2`.
- Actor, simulator, and judge: **GPT-6 Astra, low reasoning**.
- Scope: chronological shared messages and handoff fields. Private tool logs, system prompts, evaluator references, and raw API requests are not included.
- A repaired endpoint belongs to the same trial; it is not an independent repeat. Zero scores and missing scientific submissions are retained.

## Shared conversation

### Event 1 — Simulator

**Message**

````text
Please inspect the supplied brief and any available task inputs only, and report a proposed experimental approach plus consequential assumptions and uncertainties; do not produce the full design yet or execute experiments. This is design-only, so repository inspection and compute are not required. Outline how you would isolate the causal contribution of embedding chemical feedback from model, sampling-budget, and post-generation filtering effects; assess chemical-property improvement alongside real-world distribution alignment and structural diversity; and operationalize molecular hallucinations and ultra-long carbon-chain overrepresentation. Identify proposed definitions for p-logP, QED, and binding affinity, distinguishing any source-supported setup from assumptions, and flag missing choices such as targets, reference distributions, data splits, feedback implementation, and feasible evaluation resources. Briefly propose comparison arms and independent evaluation safeguards against metric exploitation or data leakage. We will review these choices before authorizing the full experiment design.
````

**Interaction**

````text
initial_request
````

**Phase**

````text
initial_inspection
````

**Action**

````text
continue
````

**Approve Approach**

````text
false
````

**Evidence**

````text
The brief asks for an experiment design rather than execution, supplies no datasets or established setup details, and explicitly states that repositories and compute are not required. No proposed approach or results have yet been reported.
````

**Objectives Open**

````text
[
  "Inspect available inputs and distinguish established details from assumptions.",
  "Review a proposed controlled design for feedback effects on properties, distribution alignment, hallucinations, and diversity.",
  "Identify consequential uncertainties before developing the final design with rationale, controls, analysis plan, and feasibility."
]
````

### Event 2 — Actor

**Answer**

````text
Proposed approach for review—not a full design

The brief poses an empirical hypothesis, not an established result. I would test whether embedded chemical feedback improves held-out chemical quality without trading away distribution alignment or structural diversity, and separate that effect from model changes, additional search, and post-generation selection.

1. Causal comparisons
• Primary matched pair: the same generator, starting checkpoint, training data, target conditioning, decoding settings, and independent seed blocks, with versus without informative embedded feedback. If feedback involves fine-tuning, use matched updates and an appropriate no-property-feedback training control.
• Search-budget control: no embedded feedback but the same number of candidate proposals and property-oracle calls. Track these budgets separately from training and inference compute; an equal-compute sensitivity comparison may also be needed.
• Filtering control: baseline generation followed by property-based ranking/filtering using the same candidate and oracle budget. Compare both raw proposals and selected outputs. Apply the same final selection rule to feedback and non-feedback generators to estimate feedback's contribution beyond selection.
• Feedback-information control: shuffled or otherwise noninformative feedback with comparable mechanics and overhead. Confirm that it preserves relevant reward scale and availability; it is a control for the information in feedback, not a perfect substitute for the primary no-feedback arm.
• If resources permit, ablate individual property terms. A different model architecture should be a separate factor, not the sole baseline.

Log all attempts, invalid proposals, duplicates, intermediate candidates, and rejected outputs. Primary comparisons should use fixed attempt/oracle budgets rather than generating indefinitely until an equal number of valid molecules is obtained. Report yield per attempt as well as quality among valid unique molecules; treat independent training/generation runs, not individual molecules alone, as replication units.

2. Proposed property definitions—none is specified by the source
• p-logP: provisionally interpret as penalized logP, not simply logP or its negative. A common convention combines computed octanol/water logP minus synthetic-accessibility and large-ring penalties, sometimes after reference-based standardization. The estimator, penalty definitions, normalization population, and optimization direction require confirmation. Do not silently pick a benchmark formula. If that interpretation is correct, separately report unpenalized logP, penalties, and a plausible lipophilicity-window score: maximizing p-logP need not improve drug suitability.
• QED: provisionally use a pinned implementation of the conventional weighted geometric-mean drug-likeness score in [0,1], higher being preferable on that surrogate. QED is not evidence of activity, safety, or synthesizability.
• Binding affinity: preferably experimentally measured, target-specific Kd or Ki, reported separately as pKd or pKi = −log10(value in molar units), higher meaning stronger affinity. IC50 is assay-dependent and should not be treated as interchangeable. If measurements are infeasible, call docking energies or model predictions affinity proxies, specify their direction and units, and avoid claiming experimentally superior binding.

3. Joint evaluation of quality, alignment, and diversity
Use held-out property distributions, multi-property success rates, and quality–diversity trade-offs, rather than a single averaged reward. Compare with an independently curated real-molecule reference for the intended chemical domain, and, where available, a separate target-relevant experimentally characterized set. A broad real-molecule reference and a target-active reference answer different alignment questions; exact agreement with the former is not necessarily desirable for targeted optimization.

Assess descriptor distributions (including size, lipophilicity, rings, heteroatoms, charge, and chain length), fingerprints/scaffolds, and held-out reference coverage. Pairwise fingerprint diversity, scaffold richness, duplicate rates, novelty relative to training data, and nearest-neighbor similarity help reveal mode collapse or memorization. Use equal-size subsampling for diversity/alignment comparisons while retaining separate all-attempt yields. Predeclare acceptable alignment/diversity loss margins rather than interpreting a nonsignificant difference as preservation.

4. Operational failure definitions
Avoid a single unsupported label of 'hallucination.' Report separately: (i) unparsable structures or invalid valence/charge, (ii) valid but pre-specified chemically implausible/problematic motifs, with independent chemist adjudication on a blinded sample where feasible, and (iii) generated claims of properties or binding not supported by independent assessment, if the system makes such claims. Novelty or being out of distribution alone is not a hallucination. Without expert/experimental confirmation, plausibility flags remain proxies.

For ultra-long carbon chains, propose the longest consecutive path of nonaromatic, acyclic carbon atoms connected by single bonds, excluding ring atoms; also report that length divided by heavy-atom count and separate size distributions. This is an explicit graph descriptor, not a full chemical naming rule. Fix an absolute cutoff with domain input and/or a high reference-set quantile before evaluating generated outputs. Report tail frequency and excess versus each relevant reference, not only maximum length. Confirm whether unsaturated chains should be counted in an additional variant. A flagged long chain is not automatically chemically invalid.

5. Independent safeguards
Separate reward construction, tuning, and final evaluation data. Deduplicate standardized molecular identities across splits and use scaffold-separated held-out evaluation; add temporal or target-held-out tests when metadata and the generalization claim justify them. Audit overlap with pretraining data to the extent accessible and disclose unknown contamination. Freeze reward weights, thresholds, selection rules, and evaluator versions before final testing. Use an independent evaluator not used for feedback—ideally orthogonal physics, independent training data, blinded expert review, or assays—rather than merely rerunning the same predictor. Report reward–evaluation disagreement and cherry-picking-resistant complete outcome distributions. Independent models remain imperfect safeguards when trained on overlapping data.

Decisions requested before full design
1. What does p-logP mean here, and are there source-specified formulas, directions, weights, or property thresholds?
2. Which generator/checkpoint and feedback implementation are intended: training updates, inference-time revision, reranking, or another mechanism?
3. Which target(s), assay endpoints, and binding evidence are relevant?
4. Which training data, real-world reference populations, splits, and contamination information are available?
5. What chain definition/cutoffs and plausibility criteria fit the intended molecule domain?
6. What generation/oracle budget and independent evaluation resources are feasible, including docking, experts, or assays?

Upon approval, I would translate these choices into a preregistered design with concrete arms, budgets, splits, endpoint hierarchy, power/precision planning, and explicit joint success criteria. No experiment is proposed to be executed at this stage.
````

**Stage**

````text
plan
````

**Evidence**

````text
Inspected only the supplied workspace listing and task.json. The workspace listing contained task.json; it restates the question and context and includes a documents entry saying 'Design-only task; repositories and compute are not required.' It does not supply a molecular dataset, code implementation, property formula, target, model, reference population, or results. The user-supplied environment reports no datasets, disabled network, no GPU, and system Python without project dependencies preinstalled. Those facts constrain immediate local feasibility but do not establish the resources available for a future study. No shell commands, experimental computation, or molecule generation were performed. The proposed controls address confounding by model capacity, search effort, and selection; separate independent endpoints address reward exploitation; multiple reference populations distinguish targeted enrichment from generic distribution matching.
````

**Assumptions**

````text
[
  "Penalized logP is only a provisional interpretation of p-logP and must be confirmed before selecting a formula.",
  "A matched generator with a switchable feedback pathway or an implementable matched control can be made available.",
  "Suitable external molecule references and at least one independent property or plausibility evaluation pathway can be obtained for a future experiment.",
  "The fixed task is design-only and concerns chemical quality, hallucinations, distribution alignment, and diversity jointly; specific models, datasets, targets, metrics, and resource allocations above are proposals, not supplied requirements."
]
````

**Uncertainties**

````text
[
  "No source-supported feedback mechanism or property definitions are supplied; the identification strategy depends on whether feedback changes training, inference, or only selection.",
  "Target choice, reference-population relevance, split feasibility, and pretraining contamination remain unresolved.",
  "Proxy-only affinity evaluation cannot establish real binding improvement; local resources do not currently include docking infrastructure or assays.",
  "Thresholds for implausibility and ultra-long chains, meaningful effect sizes, replication budgets, and preservation margins require domain and resource decisions."
]
````

### Event 3 — Simulator

**Message**

````text
Approved. Develop the final design with rationale, controls, analysis plan, and feasibility; do not execute experiments. No further source-supported setup details are available, so resolve the listed choices with explicit proposed defaults rather than treating them as confirmed facts. Choose a concrete primary feedback implementation that changes generation rather than merely reranking, and describe its matched no-feedback, budget-matched post-selection, and noninformative-feedback controls. Keep training effects separate if inference-time feedback is the primary design. Specify a reproducible provisional penalized-logP formula and normalization, with raw components and lipophilicity-window checks; explain how a different intended meaning of p-logP would change the design. Propose target/reference selection criteria and a concrete illustrative setup without claiming available datasets or resources. Retain separate broad-domain and target-relevant reference analyses, independent affinity-proxy evaluation, hallucination subtypes, and the explicit chain descriptor. Set proposed budgets, replication units, endpoint hierarchy, meaningful improvement and preservation margins, and a pilot-based power/precision procedure; clearly label numerical choices as planning assumptions. State a joint success rule requiring independent property improvement, reduced operational failures, and alignment/diversity preservation, with superiority needed to claim better alignment rather than mere preservation. Include uncertainty intervals, multiplicity handling, all-attempt denominators, missing/failed oracle handling, and equal-size diversity comparisons. Distinguish an achievable future computational study from optional blinded chemist or assay validation, and limit conclusions accordingly. Deliver one self-contained final experiment design, with no fabricated outcomes.
````

**Interaction**

````text
next_task
````

**Phase**

````text
approach_review
````

**Action**

````text
continue
````

**Approve Approach**

````text
true
````

**Evidence**

````text
The proposed approach addresses the original joint question and identifies the principal confounds: model changes, search effort, selection, reward exploitation, and leakage. It appropriately treats p-logP, the feedback mechanism, targets, and references as unspecified assumptions and separates proxy affinity from measured binding. The visible handoff contains a plan, not experimental evidence; design-only completion requires concrete proposed choices and decision criteria, not execution.
````

**Objectives Open**

````text
[
  "Produce a concrete self-contained experiment design with causal controls and explicit assumptions.",
  "Specify independent endpoints and joint statistical criteria for property gains, reduced failures, distribution alignment, and diversity.",
  "Report prospective budgets, power/precision planning, feasibility, and limits on proxy-based conclusions."
]
````

### Event 4 — Actor

**Answer**

````text
# Final proposed experiment design

## 1. Question, scope, and source status

Test whether **informative chemical feedback embedded in molecule generation**, rather than a larger model, more sampling, or downstream selection, improves independently assessed molecular quality and reduces operational chemical failures while preserving distribution alignment and structural diversity.

The supplied brief names p-logP, QED, binding affinity, hallucinations, and long-chain overrepresentation, but supplies no definitions, implementation, target, data, or results. Everything specified below beyond that question is a **proposed default**, not a recovered source setup. Numerical budgets and margins are planning assumptions to be confirmed by a disjoint pilot and then frozen. No experiment has been run.

The primary study concerns inference-time feedback with a frozen generator. Conclusions will concern computational proxies and operational failures, not demonstrated therapeutic efficacy, experimental binding, or general chemical truth.

## 2. Illustrative target, data, and reference setup

**Primary illustrative target:** human dopamine D2 receptor (DRD2). Choose it only after verifying sufficient direct, quantitative human-target Ki measurements, chemically diverse ligands, and an experimentally determined structure with a suitable ligand-binding site. A predeclared second-target replication could use human adenosine A2A receptor under the same eligibility rules; do not replace an unsuccessful target after examining treatment results.

Eligibility defaults: at least 1,000 standardized compounds with usable direct Ki measurements, at least 100 held-out compounds from at least 30 scaffold groups, a usable co-complex structure, and docking infrastructure that passes receptor-specific validation. If DRD2 fails these checks, document the failure and select the first eligible target from a registered list before generation begins.

Proposed sources, requiring future acquisition and licensing/version checks:
- A pinned ChEMBL release for experimental affinity records and a broad reference population of assay-tested small molecules.
- A pinned PDB structure for the binding site.
- A held-out, target-specific reference of measured ligands, with an active subset defined provisionally as pKi ≥ 7.

Use a fixed standardization pipeline: remove counterions, retain the principal organic component, reject ambiguous mixtures, normalize selected functional groups, and retain stereochemistry. Define the intended small-molecule domain as 10–60 heavy atoms, molecular weight 150–650, allowed elements C/H/N/O/F/P/S/Cl/Br/I, and formal charge −2 to +2. **Do not quietly filter generated violations:** count them as domain failures and retain their descriptors where computable. Reference restrictions define the intended domain, not a license to remove inconvenient generated outputs.

Construct scaffold-grouped 70/15/15 train/development/test splits after standardized-identity deduplication. Aggregate compatible measurements within compounds; do not merge Ki, Kd, and IC50 as equivalent labels. Freeze test references before reward-model fitting. Use a temporal sensitivity split if dates permit. References should include:
1. **Broad-domain test reference:** representative assay-tested small molecules in the chosen domain, explicitly not all molecules occurring in nature or commerce.
2. **Target-relevant test reference:** measured target ligands, with active and all-measured subsets reported separately. These data have assay-selection bias and are not a representative set of true inactives.

Audit generated novelty and nearest neighbors against all accessible generator and reward training data. Unknown foundation-model pretraining contamination remains a limitation, even with perfect downstream splits.

## 3. Concrete primary feedback implementation

Use one frozen, SMILES-capable instruction generator supporting molecular revision. Select and register one checkpoint, tokenizer, prompt template, decoding temperature (proposed 0.8), top-p (0.95), context limit, and maximum output tokens (256) before the pilot. All arms use identical weights, target conditioning, decoding, and fixed output format: one candidate SMILES per call. Model selection must not use final evaluation results.

Each run contains **128 independent trajectories and eight proposals per trajectory**, totaling **1,024 attempts**. Round 1 generates molecules from the same target prompt. Rounds 2–8 ask for a revised molecule using the trajectory's latest syntactically valid candidate; when the latest candidate is invalid, retain the previous valid parent. If none exists, use the initial prompt. This parser-only state update is identical across arms and is not property-based acceptance.

The informative arm supplies a structured feedback vector containing the candidate's p-logP and components, QED, predicted pKi, domain/validity flags, and a fixed scalar reward. The prompt asks for a new structure improving the reward while retaining chemically plausible, target-appropriate small-molecule character. No best-of-round acceptance, beam selection, or property-based stopping is permitted. Feedback therefore changes the distribution of subsequent proposals rather than merely selecting from a fixed pool.

Proposed reward:

R = 0.20 sigmoid(p-logP/2) + 0.30 QED + 0.50 sigmoid(predicted pKi − 6.5).

Invalid or out-of-domain structures receive R = 0 and explicit failure flags. The coefficients, sigmoid scales, and predicted-affinity threshold are provisional. No fitting of these values to final test performance is allowed. A fixed reward predictor trained on training-only target Ki data supplies predicted pKi; use a pinned fingerprint-based regressor with development-only hyperparameter selection and an applicability-domain flag. Missing predictor values are explicitly reported, not replaced by optimistic scores.

### Matched arms

**A. Informative embedded feedback:** the revision procedure above.

**B. No informative feedback:** identical trajectory structure, parent rule, target prompt, and generic request to revise, but numerical feedback fields are masked. Reserve the same input field sizes. Score candidates in a hidden shadow process for budget accounting and later analysis; these values never reach the generator.

**C. Budget-matched post-selection only:** use B's candidate pools and rank them after generation by R, returning the top 128 unique valid candidates. This is a distinct evaluated pipeline, not an unnecessarily duplicated random generation run. Apply exactly the same top-128 rule to A and D as well. Compare A versus B on raw pools and A-selected versus C on selected outputs. Thus selection alone cannot explain the primary raw-pool contrast, and the selected-pool contrast tests whether feedback adds value beyond ranking.

**D. Noninformative feedback:** same process as A, but each round's complete feedback vectors are randomly permuted between trajectories using a derangement. Preserve the vector's internal correlations, missingness, and scale while breaking its link to the recipient molecule. Record residual molecule–feedback associations; this is a mechanistic negative control, not a guarantee of perfectly neutral feedback.

Generate 20 paired seed blocks for A, B, and D; C reuses B. Pair round-1 candidates and random-number schedules where feasible. Different downstream trajectories remain expected. That is **61,440 total generator attempts per target**, with 20 independent run blocks as the replication units. A second target doubles this budget.

All arms have identical attempt limits, oracle-call opportunities, maximum token budgets, and candidate caching rules. Record actual tokens, GPU/CPU time, oracle cache hits, and latency. Repeated molecules consume attempts but need not consume duplicate oracle computation. Report both requested and actual unique oracle calls. An equal-wall-clock sensitivity analysis may supplement, but not replace, the equal-attempt analysis.

Keep training separate: no generator fine-tuning occurs here. Any subsequent training-feedback experiment needs fresh checkpoints, matched optimizer updates, training data, compute, and independent replications and must not be pooled with inference-time effects.

## 4. Reproducible provisional property definitions

### Penalized logP

Provisionally define p-logP as penalized logP:

p-logP(m) = [L(m) − μL]/σL − [S(m) − μS]/σS − [C(m) − μC]/σC.

- L: RDKit Crippen MolLogP.
- S: pinned RDKit-contrib Ertl–Schuffenhauer synthetic-accessibility score, including a checksum of the fragment-score resource; larger scores are worse.
- C: max(0, largest cycle-basis ring length − 6), or zero for acyclic molecules. Use NetworkX `cycle_basis` on a canonically renumbered heavy-atom graph, fixed root and neighbor ordering, and pinned versions. This explicitly chooses a reproducible cycle-basis convention rather than claiming all ring definitions agree.
- Means and population standard deviations: computed once from the standardized broad-domain **training** reference, then frozen for every arm and target. If any standard deviation is zero, use 1 and disclose it.

Report raw L, S, C and their distributions, not just the composite. Larger p-logP is the optimization convention, not a universal chemical preference. Report the fraction with **1 ≤ raw logP ≤ 4** and mean distance outside that window; this window is a planning assumption rather than a universal drug-likeness rule.

If the intended p-logP instead means predicted logP, a different benchmark penalization, or another property, replace this formula, reward scaling, and associated thresholds before the study and re-pilot. Retain raw logP and window checks. Results from this provisional formula cannot be relabeled as evidence for another definition.

### QED

Use pinned RDKit `QED.qed` with its default mean descriptor weights, giving a weighted geometric-mean drug-likeness score in [0,1]. Higher is preferred on this surrogate. QED neither proves binding nor supplies independent evidence of safety or synthetic feasibility.

### Affinity and its independent proxy

Training labels are **pKi = −log10(Ki in mol/L)**; higher is stronger measured affinity. Report Kd separately as pKd if used in supplemental validation. Do not equate IC50 with either endpoint.

The reward uses predicted pKi. Independent evaluation uses a frozen docking protocol, for example AutoDock Vina with fixed receptor preparation, protonation rules, box, conformer generation, exhaustiveness, and docking seeds. Lower docking energies are better; they are not measurements of Ki or calibrated binding free energies.

Before generation, require a provisional co-crystal redocking heavy-atom RMSD ≤ 2 Å and evidence of enrichment on a separate development panel of known ligands and matched controls. Freeze preparation choices and thresholds after this check. Failure means affinity conclusions are unsupported until an alternative protocol is qualified; do not tune docking on generated outputs.

A frozen independent-proxy hit requires docking score at least as favorable as the median score of a separate calibration set of measured actives, plus passage of predeclared pose/clash checks. Calibrate separately for each target. Dock all unique valid generated structures when feasible and reuse cached results across arms. This evaluator is never exposed to the generator, reward model, or selection rule. Shared physicochemical biases remain possible, so also examine heavy-atom-matched and lipophilicity-matched sensitivity comparisons.

## 5. Endpoint hierarchy and failure definitions

### Confirmatory endpoints

**Property benefit:** all-attempt fraction satisfying independent docking-hit criteria, QED ≥ 0.6, raw logP within [1,4], and intended-domain checks. Invalid structures and failed mandatory evaluations are nonsuccesses. Proposed meaningful gain: **5 percentage points** for A versus B and for A-selected versus C. Also require a **3-point gain in independent docking-hit fraction alone**, so the composite cannot improve exclusively through QED/logP.

**Operational failures:** all-attempt union of unparsable SMILES, sanitization/valence failures, out-of-domain structures, and predeclared high-concern structure flags. Proposed meaningful reduction: **2 percentage points** in A versus B. Report every subtype separately and clarify that domain violations and structural alerts need not represent impossible chemistry. If baseline failures are already below 2%, the strong reduction claim is not identifiable with this margin; a floor-effect limitation is preferable to redefining success after seeing results.

**Alignment preservation:** distance from each held-out reference using (a) mean training-standardized Wasserstein-1 distance over a fixed panel of molecular weight, heavy-atom count, logP, TPSA, QED, ring count, heteroatom fraction, charge, and chain length, and (b) MMD using a fixed Tanimoto kernel on Morgan radius-2, 2,048-bit fingerprints. Standardize each distance by its B-arm mean from the separate pilot. Proposed noninferiority margin: an increase of at most **0.10 normalized distance units**. Require preservation for broad-domain and target-relevant references separately.

**Diversity preservation:** mean pairwise Tanimoto distance and effective Bemis–Murcko scaffold diversity, with all acyclic molecules assigned a declared acyclic category. Proposed margins: no decrease exceeding **0.02** in pairwise diversity or **10%** in effective scaffold diversity. Report uniqueness, scaffold counts, training novelty, and reference coverage as supporting endpoints.

### Hallucination subtypes

1. **Representation/chemistry failures:** parse, sanitization, or valence failures.
2. **Plausibility/domain flags:** off-domain molecules or fixed reactive/unstable-motif alerts. Keep generic assay-interference alerts separate; an alert is not proof a molecule cannot exist.
3. **Unsupported property claims:** relevant only if a generator makes explicit claims; the primary SMILES-only protocol makes none. Reward–independent-evaluator disagreement is instead reported as proxy exploitation, not automatically a false chemical claim.

Optional blinded chemist review can estimate how often valid flagged and unflagged structures are judged implausible, using stratified sampling and prevalence weights. Without it, conclusions concern operational failure rates, not an exhaustive hallucination rate.

### Ultra-long chains

Define chain length as the longest path of nonaromatic, acyclic carbon atoms connected by single bonds, excluding ring atoms. Its induced subgraph is acyclic, enabling a reproducible longest-path calculation. Report absolute length, length/heavy-atom count, and heavy-atom-count distributions.

Proposed absolute ultra-long threshold: **length ≥ 12**. Also report excess above each reference's frozen 99th percentile, calculated before generation; use strict exceedance to handle ties. Preserve tail frequency within **1 percentage point** of B's frequency, and report excess prevalence versus each reference. Add a predeclared sensitivity descriptor allowing double/triple carbon–carbon bonds. Long chains are a distributional concern, not inherently hallucinations.

## 6. Analysis and joint decision rule

Maintain three views: all attempted proposals, valid unique raw pools, and top-128 selected outputs. Report failures and duplicate rates with **all 1,024 attempts as the denominator**; repeated successful structures may count toward attempt success but must be exposed through uniqueness and diversity endpoints. Selected-output success uses 128 intended output slots; unfilled slots are failures. No replacement generation is allowed.

For alignment/diversity, subsample equal sizes using fixed repeated subsampling: proposed 256 valid unique raw molecules and 64 selected molecules per run, and equal-size reference samples. If the pilot shows these counts are infeasible, choose smaller counts before confirmation. In confirmation, a deficient run is a coverage failure; do not silently discard it or shrink all pools post hoc. Report valid-only distances explicitly alongside coverage and all-attempt failure rates.

Use run-level paired effects, with paired block-bootstrap uncertainty intervals; molecule counts are not independent replication. Provide 95% intervals for effects, reference distances, subtype rates, chain-tail excess, and selected-output yields. Use nested reference resampling to quantify finite-reference uncertainty and report target-specific results rather than treating targets as interchangeable replicates.

**Strong joint success requires:**
1. Independent property benefit meeting the proposed margins in raw and selected comparisons, including independent docking-hit improvement.
2. Reduced operational failure rate meeting its margin.
3. Alignment and diversity noninferiority for raw and selected outputs, with chain-tail preservation and adequate unique-output yield.

For meaningful improvement, require the lower one-sided confidence bound to exceed the relevant benefit margin; for preservation require the adverse-effect upper bound to remain within its margin. This is deliberately stricter than merely obtaining a favorable point estimate. Compare A versus D to test informative-feedback specificity; failure to outperform D weakens attribution to chemical information even if A beats B.

To claim **better alignment**, require superiority, not merely preservation: a reduction of at least **0.10 normalized distance units** on both registered alignment metrics for the named reference, with simultaneous uncertainty bounds supporting it. Claiming improvement for both real-world references requires both to pass. Target-relevant enrichment alone does not establish better broad-domain alignment.

Treat the strong claim as an intersection–union test: every required component must pass at one-sided α = 0.025. Use Holm correction for separately advertised superiority claims across references/targets and mechanistic A-versus-D claims. Label unregistered analyses exploratory; report effect sizes and intervals even when the joint rule fails.

Missing/failed oracles: allow one fixed retry for infrastructure failures, identical across arms. Log chemistry-related, applicability-domain, timeout, and infrastructure causes separately. Mandatory-evaluation failures count as primary nonsuccesses, but infrastructure outages are not chemical hallucinations. If unresolved infrastructure failures exceed a proposed 2% of attempts, pause and repair or declare the run inconclusive rather than score an arm unfairly. Report missingness by arm and best/worst-case sensitivity bounds; do not use complete-case affinity means as the primary endpoint.

## 7. Pilot, power, and safeguards

Run a future pilot of **five independent blocks per generated arm**, using separate seeds and development data only. It checks parsing, oracle throughput, missingness, reward scale, docking qualification, control implementation, and feasible pool sizes; it does not contribute confirmatory results.

Using pilot run-level variances/covariances, simulate paired confirmatory analyses for 20–60 blocks. Seek **90% joint power** under explicit planning alternatives, for example a 10-point composite-property gain, 6-point independent-hit gain, 4-point failure reduction, and no true preservation loss. Also target 95% interval half-widths around 2.5 points for primary success and 1 point for failures. Use a conservative upper variance estimate or sensitivity range because five pilot blocks are small. Choose the smallest feasible count meeting the goals, capped at 60; if none works, report an underpowered feasible design or renegotiate resources before confirmation. Do not alter margins to manufacture power. No unplanned efficacy stopping.

Freeze datasets, versions, structure preparation, seeds, analysis code, thresholds, standardization, and reward weights before confirmation. Blind independent evaluator operators and any chemists to arms where practical. Audit a sample of logs to ensure B/C did not receive hidden scores and A never received independent docking results. Report all arms, targets, failed runs, and attempts.

## 8. Feasibility and interpretation

An achievable future computational study needs acquired/versioned data, an accessible generator checkpoint, model inference hardware or a fixed API, cheminformatics dependencies, and validated docking resources. The base single-target design requests 61,440 generator calls and at most that many unique independent docking evaluations; pilot timing determines CPU-hours and actual feasibility. C adds selection analysis, not another generation pool. Larger replication or a second target increases cost transparently. These resources are not present in the supplied workspace, and no execution is proposed here.

Optional validation: blinded chemist review of both random and flagged samples; subsequently, synthesize or purchase a budgeted, diversity-stratified sample from each selected arm and measure target binding in the same blinded assay. Include a randomized selection component so validation is not only of investigators' favorite molecules. Assay confirmation warrants a stronger binding claim; computational success alone supports improved independent affinity proxies, operational chemical quality, and reference-relative alignment/diversity under the registered setup—not experimentally superior drugs.
````

**Stage**

````text
result
````

**Evidence**

````text
Inspection found only task.json in the supplied workspace. It contains the task question, context, and a documents entry stating that this is design-only and repositories/compute are not required. It supplies no implementation, data, targets, reference distributions, formulas, or outcomes. The user reports disabled network, no GPU, no supplied datasets, and no preinstalled project dependencies. No experiments or exploratory computation were executed. The frozen-generator design isolates inference-time information; paired generation and reused baseline pools separate feedback from post-selection; shadow oracle accounting separates information access from sampling opportunity. Frozen independent docking provides an evaluation channel distinct from reward prediction, while its limitations are explicitly retained. Separate reference populations and all-attempt versus valid-unique analyses prevent selection and invalid-output removal from masquerading as distribution alignment. The numerical choices are planning defaults subject to a disjoint feasibility/power pilot, not empirical findings.
````

**Assumptions**

````text
[
  "All named targets, datasets, tools, model settings, budgets, thresholds, margins, and formulas are proposed defaults; the fixed task requirements are design-only assessment of chemical feedback, property improvement, hallucinations, real-world distribution alignment, and diversity.",
  "p-logP provisionally means the explicitly normalized penalized-logP score in the design; another intended meaning requires preregistration changes before confirmation.",
  "A suitable frozen molecular instruction generator and future computational resources can be obtained; no specific checkpoint or resource availability was supplied.",
  "Proposed DRD2 data and structural eligibility must be verified before committing to that illustrative target.",
  "Independent docking can be qualified sufficiently for a computational proxy study, but it does not establish measured binding affinity.",
  "The pilot may change replication counts and feasible equal-size sampling counts before confirmation, but not silently change the scientific question or loosen meaningful-effect margins."
]
````

**Uncertainties**

````text
[
  "Exact model checkpoint, dataset versions, record counts, receptor structure, assay compatibility, and pretrained-data overlap remain acquisition-stage uncertainties.",
  "Five pilot blocks may estimate run-level variance poorly; conservative sensitivity estimates and a replication cap are specified rather than guaranteeing power.",
  "Broad assay-tested chemical space and observed target ligands are biased reference populations; conclusions must name them rather than generalize to all real-world molecules.",
  "Independent docking may share size/lipophilicity biases with reward predictors or fail receptor-specific qualification; matched sensitivities do not fully eliminate this risk.",
  "Low baseline failure rates can make the proposed meaningful failure reduction unattainable; this limits the strong joint claim rather than licensing a post hoc definition change.",
  "Expert and experimental validation are optional extensions requiring separate resources, and are necessary for stronger chemical-plausibility and real-binding conclusions."
]
````

### Event 5 — Simulator

**Message**

````text
The final design satisfies the design-only deliverable: it provides a concrete embedded-feedback intervention, matched causal controls, explicit provisional property definitions, independent proxy evaluation, separate reference-population analyses, operational failure and chain-tail endpoints, a joint decision rule, replication and power planning, and feasibility limitations. Retain the stated acquisition-stage uncertainties and proposed defaults as such. No experimental execution or empirical outcome is claimed, and computational affinity-proxy success must not be presented as measured binding improvement.
````

**Interaction**

````text
conclude
````

**Phase**

````text
result_review
````

**Action**

````text
stop
````

**Approve Approach**

````text
false
````

**Evidence**

````text
The reported design holds generator weights fixed, contrasts informative and masked feedback with permuted-feedback controls, and reuses baseline pools to isolate post-selection. It specifies all-attempt denominators, equal-size diversity comparisons, missing-oracle handling, run-level uncertainty, preservation margins versus alignment superiority, and a disjoint pilot. Future resources and unresolved model/data choices are explicitly distinguished from available inputs. These elements adequately answer the original experiment-design request without requiring execution.
````

**Objectives Open**

````text
[]
````

## Provenance

````text
{
  "source_run": "runs/openai-astra-top2-first-pass",
  "repair_run": "runs/repair-1-openai-astra-top2-first-pass",
  "event_log": "runs/openai-astra-top2-first-pass/episodes/expbench_iclr2024_19281_1-0aedaf6a9390/persona_off/attempt-1/output/iclr2024__19281__1/events.jsonl",
  "event_log_sha256": "67215524a0116e3ae82faaedaef0951df7e0c8562b5959cbc1ea54971f133774",
  "models": {
    "actor": {
      "model": "gpt-6-astra",
      "provider": "openai",
      "reasoning_effort": "low"
    },
    "researcher": {
      "model": "gpt-6-astra",
      "provider": "openai",
      "reasoning_effort": "low"
    },
    "judge": {
      "model": "gpt-6-astra",
      "provider": "openai",
      "reasoning_effort": "low"
    }
  }
}
````
